Laboratorio Reig Jofre SA

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: ES0165359029

EUR

2.76

-0.02 (-0.72%)

Dec 12

MCE

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Faes Farma SA

Laboratorios Farmaceúticos Rovi SA

Almirall SA

Grifols SA

Laboratorio Reig Jofre SA

Labiana Health SA

Why is Laboratorio Reig Jofre SA ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.49%

Poor long term growth as Operating profit has grown by an annual rate 5.72% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

With ROE of 2.98%, it has a Very Expensive valuation with a 1.13 Price to Book Value

Over the past year, while the stock has generated a return of 1.47%, its profits have fallen by -30.4%

Underperformed the market in the last 1 year

The stock has generated a return of 1.47% in the last 1 year, much lower than market (Spain IBEX 35) returns of 43.21%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Laboratorio Reig Jofre SA for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Laboratorio Reig Jofre SA

5.34%

-0.24

25.72%

Spain IBEX 35

43.26%

2.49

17.33%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

10.75%

EBIT Growth (5y)

5.72%

EBIT to Interest (avg)

8.14

Debt to EBITDA (avg)

1.12

Net Debt to Equity (avg)

0.20

Sales to Capital Employed (avg)

0.92

Tax Ratio

12.31%

Dividend Payout Ratio

30.60%

Pledged Shares

Institutional Holding

ROCE (avg)

4.49%

ROE (avg)

3.74%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.13

EV to EBIT

35.02

EV to EBITDA

9.26

EV to Capital Employed

1.11

EV to Sales

0.89

PEG Ratio

Dividend Yield

0.32%

ROCE (Latest)

3.16%

ROE (Latest)

2.98%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

Bearish

No Signal

Bollinger Bands

Bearish

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is working for Laboratorio Reig Jofre SA

Operating Cash Flow - Annually

Highest at EUR 19.12 MM and Grown

each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (EUR MM)

Here's what is not working for Laboratorio Reig Jofre SA

Dividend Payout Ratio (DPR) - Annually

Lowest at 0.00 %

in the last five years

MOJO Watch

Company is distributing lower proportion of profits generated as dividend

DPR (%)